Theravance and Janssen to Advance TD-1473 for Treatment of Inflammatory Bowel Diseases
News
Theravance Biopharma Ireland Limited, a Theravance Biopharma subsidiary, and Janssen Biotech have joined forces to develop and commercialize the investigational therapy TD-1473 as a treatment for inflammatory bowel diseases (IBDs) such ... Read more